{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T12:10:21Z","timestamp":1739967021005,"version":"3.37.3"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1124\/mol.107.035873","type":"journal-article","created":{"date-parts":[[2007,6,19]],"date-time":"2007-06-19T00:53:39Z","timestamp":1182214419000},"page":"744-752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Perturbation of Dopamine Metabolism by 3-Amino-2-(4\u2032-halophenyl)propenes Leads to Increased Oxidative Stress and Apoptotic SH-SY5Y Cell Death"],"prefix":"10.1016","volume":"72","author":[{"given":"Warren C.","family":"Samms","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan P.","family":"Perera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.S.","family":"Wimalasena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Wimalasena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.107.035873_REF1","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2174\/0929867013372995","article-title":"Parkinson\u2019s disease\u2013redox mechanisms","volume":"8","author":"Adams","year":"2001","journal-title":"Curr Med Chem"},{"key":"10.1124\/mol.107.035873_REF2","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/S0021-9258(17)35819-2","article-title":"Reducing equivalents across chromaffin granule membrane","volume":"261","author":"Beers","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.035873_REF3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1124\/mol.107.035873_REF4","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"80","author":"Burns","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/mol.107.035873_REF5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0197-0186(97)00031-4","article-title":"Free radicals and the pathobiology of brain dopamine systems","volume":"32","author":"Cadet","year":"1998","journal-title":"Neurochem Int"},{"key":"10.1124\/mol.107.035873_REF6","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1016\/S0021-9258(18)60674-X","article-title":"Energy-driven uptake of the neurotoxin 1-methyl-4-phenylpyridinium into chromaffin granules via the catecholamine transporter","volume":"263","author":"Daniels","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.035873_REF7","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1021\/ic00062a045","article-title":"Mono-and binuclear molybdenum and tungsten complexes containing asymmetric bridging ligands: effects of ligand conjugation and conformation on metal-metal interactions","volume":"32","author":"Das","year":"1993","journal-title":"Inorg Chem"},{"key":"10.1124\/mol.107.035873_REF8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","article-title":"Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability","volume":"89","author":"Denizot","year":"1986","journal-title":"J Immunol Methods"},{"key":"10.1124\/mol.107.035873_REF9","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/mol.107.035873_REF10","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1073\/pnas.86.16.6377","article-title":"Ascorbate is an outstanding antioxidant in human blood plasma","volume":"86","author":"Frei","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/mol.107.035873_REF11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0003-9861(86)90526-6","article-title":"Biological effects of the superoxide radical","volume":"247","author":"Fridovich","year":"1986","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/mol.107.035873_REF12","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0026-895X(25)13535-9","article-title":"Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones","volume":"14","author":"Graham","year":"1978","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.107.035873_REF13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.expneurol.2005.01.013","article-title":"Oxidative stress and inflammation in Parkinson\u2019s disease: is there a casual link?","volume":"193","author":"Hald","year":"2005","journal-title":"Exp Neurol"},{"key":"10.1124\/mol.107.035873_REF14","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1471-4159.2006.03907.x","article-title":"Oxidative stress and neurodegeneration: where are we now?","volume":"97","author":"Halliwell","year":"2006","journal-title":"J Neurochem"},{"key":"10.1124\/mol.107.035873_REF15","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1073\/pnas.0407737102","article-title":"Amphetamine induces dopamine efflux through a dopamine transporter channel","volume":"102","author":"Kahlig","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/mol.107.035873_REF16","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1124\/mol.106.023952","article-title":"Regulation of dopamine transporter trafficking by intracellular amphetamine","volume":"70","author":"Kahlig","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.107.035873_REF17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0092-8674(92)90425-C","article-title":"A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter","volume":"70","author":"Liu","year":"1992","journal-title":"Cell"},{"key":"10.1124\/mol.107.035873_REF18","doi-asserted-by":"crossref","first-page":"38581","DOI":"10.1074\/jbc.M005385200","article-title":"The Parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation","volume":"275","author":"Lotharius","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.035873_REF19","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1089\/ars.2006.8.1997","article-title":"Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders","volume":"8","author":"Mattson","year":"2006","journal-title":"Antioxid Redox Signal"},{"key":"10.1124\/mol.107.035873_REF20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0006-291X(83)91274-3","article-title":"Dopamine-?-hydroxylase: suicide inhibition by the novel olefinic substrate, 1-phenyl-1-aminomethylethene","volume":"110","author":"May","year":"1983","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/mol.107.035873_REF21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1021\/jm00380a007","article-title":"Enzyme-activated irreversible inhibitors of monoamine oxidase: phenylallylamine structure-activity relationships","volume":"28","author":"McDonald","year":"1985","journal-title":"J Med Chem"},{"key":"10.1124\/mol.107.035873_REF22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/cyto.990120408","article-title":"Flow cytometric monitoring of glutathione content and anthracycline retention in tumor cells","volume":"12","author":"Nair","year":"1991","journal-title":"Cytometry"},{"issue":"Suppl 4","key":"10.1124\/mol.107.035873_REF23","first-page":"IV23","article-title":"L-DOPA treatment from the viewpoint of neuroprotection. Possible mechanism of specific and progressive dopaminergic neuronal death in Parkinson\u2019s disease","volume":"252","author":"Ogawa","year":"2005","journal-title":"J Neurol"},{"key":"10.1124\/mol.107.035873_REF24","doi-asserted-by":"crossref","first-page":"9505","DOI":"10.1073\/pnas.181319898","article-title":"Mitochondria play no roles in Mn(II)-induced apoptosis in HeLa cells","volume":"98","author":"Oubrahim","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/mol.107.035873_REF25","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.1021\/bi00342a021","article-title":"Olefin oxygenation and n-dealkylation by dopamine b-monooxygenase: catalysis and mechanism-based inhibition","volume":"24","author":"Padgette","year":"1985","journal-title":"Biochemistry"},{"key":"10.1124\/mol.107.035873_REF26","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1021\/jm030004p","article-title":"Characterization of a series of 3-amino-2-phenylpropene derivatives as novel bovine chromaffin vesicular monoamine transporter inhibitors","volume":"46","author":"Perera","year":"2003","journal-title":"J Med Chem"},{"key":"10.1124\/mol.107.035873_REF27","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","article-title":"The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety","volume":"76","author":"Przedborski","year":"2001","journal-title":"J Neurochem"},{"key":"10.1124\/mol.107.035873_REF28","doi-asserted-by":"crossref","first-page":"E847","DOI":"10.1208\/aapsj070481","article-title":"Role of monoamine transporters in mediating psychostimulant effects","volume":"7","author":"Riddle","year":"2005","journal-title":"AAPS J"},{"key":"10.1124\/mol.107.035873_REF29","series-title":"Neurotransmitter Transporters: Structure, Function and Regulation","first-page":"73","article-title":"Mechanisms of biognic amine transporters","author":"Rudnick","year":"1997"},{"key":"10.1124\/mol.107.035873_REF30","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1073\/pnas.89.5.1817","article-title":"The molecular mechanism of \u201cEcstasy\u201d [3,4-methylenedioxymethamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release","volume":"89","author":"Rudnick","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/mol.107.035873_REF31","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0960-9822(92)90320-A","article-title":"Transporters of delight","volume":"2","author":"Sabol","year":"1992","journal-title":"Curr Biol"},{"key":"10.1124\/mol.107.035873_REF32","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0026-895X(25)13357-9","article-title":"Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters","volume":"44","author":"Schuldiner","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.107.035873_REF33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal Biochem"},{"key":"10.1124\/mol.107.035873_REF34","first-page":"341","article-title":"Cytotoxic effects of MPTP on SH-SY5Y human neuroblastoma cells","volume":"18","author":"Song","year":"1997","journal-title":"Neurotoxicology"},{"key":"10.1124\/mol.107.035873_REF35","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1073\/pnas.97.22.11869","article-title":"Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles","volume":"97","author":"Sulzer","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/mol.107.035873_REF36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1021\/jm00223a008","article-title":"Potential oxidative pathways of brain catecholamines","volume":"19","author":"Tse","year":"1976","journal-title":"J Med Chem"},{"key":"10.1124\/mol.107.035873_REF37","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1016\/S0021-9258(18)67577-5","article-title":"Functional coupling between enzymes of chromaffin granule membrane","volume":"261","author":"Wakefield","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.035873_REF38","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/jpet.104.071381","article-title":"Rotenone induces apoptosis via activation of Bad in human dopaminergic SH-SY5Y cells","volume":"311","author":"Watabe","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.107.035873_REF39","doi-asserted-by":"crossref","first-page":"15298","DOI":"10.1074\/jbc.M313325200","article-title":"Kinetic evidence for channeling of dopamine between monoamine transporter and membranous dopamine-\u03b2-monooxygenase in chromaffin granule ghosts","volume":"279","author":"Wimalasena","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.035873_REF40","first-page":"27516","article-title":"The reduction of membrane-bound dopamine \u03b2-monooxygenase in resealed chromaffin granule ghosts","volume":"270","author":"Wimalasena","year":"1995","journal-title":"Is intragranular ascorbic acid a mediator for extragranular reducing equivalents? J Biol Chem"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X2404570X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X2404570X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.107.035873","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:55:01Z","timestamp":1739966101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X2404570X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0026895X2404570X"],"URL":"https:\/\/doi.org\/10.1124\/mol.107.035873","relation":{},"ISSN":["0026-895X"],"issn-type":[{"type":"print","value":"0026-895X"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perturbation of Dopamine Metabolism by 3-Amino-2-(4\u2032-halophenyl)propenes Leads to Increased Oxidative Stress and Apoptotic SH-SY5Y Cell Death","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.107.035873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}